BeStock  
Stocks › Biotechnology › INCY

Incyte INCY

US equityMarket cap rank #824BiotechnologyCAR-T Therapy
$114.63 −$1.25 (-1.07%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $114.63 0.00%
Open$116.85
Prev close$115.87
Day range$114.28 – $117.51
Volume1.54M
Market cap$23.36B
P/E (TTM)58.5
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings58.5x
CheapRich

Above its usual level · 79th percentile, 5-year average 107.5x

#2680 of 2996 stocks by PE (1 = cheapest)

Price / book4.1x
CheapRich

Above its usual level · 69th percentile, 5-year average 3.7x

#4293 of 5338 stocks by PB (1 = cheapest)

Price / sales3.9x
CheapRich

Around its usual level · 48th percentile, 5-year average 4.1x

#3742 of 5161 stocks by PS (1 = cheapest)

P/E over five years

-173x211x595x979xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$100.00
Price vs. fair value+14.6%Trading above the estimate
Star rating★★☆☆☆
Economic moatNone
UncertaintyMedium
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 4.14 – 3.73 69% (pricier than usual) #4293 of 5338 (1 = cheapest)
PE 58.48 21.47 107.51 79% (pricier than usual) #2680 of 2996 (1 = cheapest)
PS 3.89 3.86 4.09 48% (cheaper than usual) #3742 of 5161 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on INCY.

Sign in to join the discussion.

Scroll to Top